Read the latest news from the EMBL Partnerships below:
Heidelberg, 12 September 2016 New EMBL-Hubrecht Institute partnership EMBL and the Hubrecht Institute in Utrecht, the Netherlands, have signed an agreement establishing the EMBL-Hubrecht Partnership for Stem Cell and Tissue Biology. Building upon existing links between the two organisations, the partnership aims to establish a working relationship to support scientific exchange and complementarity. Working at the interface of stem cell and tissue biology, researchers in this partnership will investigate how human tissues and organs develop and are organised, advancing our understanding of a wide range of diseases, including heart degeneration, Alzheimer's, diabetes and tumours.
Heidelberg, 14 July 2016 How new HIV drugs lock virus in immaturity A new type of HIV drug currently being tested works in an unusual way, scientists in the Molecular Medicine Partnership Unit, a collaboration between EMBL and Heidelberg University Hospital, have found. Led by John Briggs at EMBL and Hans-Georg Kräusslich at Heidelberg University Hospital, they also discovered that when the virus became resistant to early versions of these drugs, it did not do so by blocking or preventing their effects, but rather by circumventing them. The study, published online in Science, presents the most detailed view yet of part of the immature form of HIV.
Grenoble, 7 June 2016 Partnership for Structural Biology: strength in diversity The Partnership for Structural Biology (PSB) brings together researchers working at various institutes based at the European Photon and Neutron (EPN) science campus in Grenoble. Through the PSB, researchers based at EMBL, ILL, ESRF, and the Institut de Biologie structural (IBS) can collaborate with and access resources and expertise from all institutes. The PSB agreement was renewed for five more years in February 2016, strengthening the position of EMBL and the other members of the Grenoble-based partnership as leaders in protein studies.
General, 29 September 2015 Northern highlights EMBL’s remote partnerships with national institutes in the member states are ‘remote’ only in name: these collaborations aim to belie borders, unifying scientists and complementary science to spur transfer of research excellence and know-how in training, governance and recruitment. Recent activities in the Nordic countries demonstrate how effective these networks have become: renewal of EMBL’s partnership with the Sars International Centre for Marine Molecular Biology in Norway for a further 10 years, and the annual meeting of the Nordic EMBL Partnership for Molecular Medicine.
Heidelberg, 28 July 2015 Union makes success With the goal of joining forces to further scientific and medical research, EMBL and the Medical Faculty of the University of Heidelberg have renewed the successful Molecular Medicine Partnership Unit (MMPU) agreement until 2025. The two complementary research institutions will continue to share data and resources, and together achieve scientific and medical breakthroughs that each individually may not have been able to make. “This kind of close collaboration really bridges the gap between basic and medical research and brings strong additional value to both institutions,” explains Matthias Hentze, Director of EMBL.
Hinxton, 8 March 2015 Supporting women in science The Wellcome Genome Campus is marking International Women’s Day 2015 by giving its first Best Practice Award for Supporting Women in Science. The recipients are John Overington of EMBL-EBI and Laura Huckins of the Wellcome Trust Sanger Institute. Everyone on campus, scientific and non-scientific alike, were invited to nominate a colleague who had made a positive difference to women’s careers.
Heidelberg, 6 February 2015 The battle for iron The search for therapies against anaemia of chronic disease (ACD) could take on new directions thanks to a study published today in Blood. In it, scientists in the Molecular Medicine Partnership Unit, a joint venture of EMBL and Heidelberg University Clinic, have found a hitherto unknown way through which mice starve pathogens of iron.
Grenoble, 19 November 2014 In full view Scientists looking to understand – and potentially thwart – the influenza virus now have a much more encompassing view, thanks to the first complete structure of one of the flu virus’ key machines. The structure, obtained by scientists at EMBL Grenoble, allows researchers to finally understand how the machine works as a whole, and could prove instrumental in designing new drugs to treat serious flu infections and combat flu pandemics.
Heidelberg, 2 November 2014 Same pieces, different picture Scientists at EMBL Heidelberg have obtained the first structure of the immature form of HIV at a high enough resolution to pinpoint exactly where each building block sits in the virus. The study reveals that the building blocks of the immature form of HIV are arranged in a surprising way.